Open AccessThe Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
Author(s) -
Myeong Geun Choi,
Byong Duk Ye,
SukKyun Yang,
Tae Sun Shim,
KyungWook Jo,
Sang Hyoung Park
Publication year - 2022
Publication title -
journal of korean medical science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.743
H-Index - 66
eISSN - 1598-6357
pISSN - 1011-8934
DOI - 10.3346/jkms.2022.37.e107
Subject(s) - vedolizumab , medicine , ustekinumab , latent tuberculosis , ulcerative colitis , tuberculosis , inflammatory bowel disease , crohn's disease , infliximab , mycobacterium tuberculosis , disease , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom